Claudia Teo

Claudia Teo

Partner
Head, Corporate and Financial Services
T: 
+65 6361 9392
F: 
+65 6438 1788
E: 
ClaudiaTeo@harryelias.com

Claudia is Head of the Corporate and Financial Services Practice Group in Singapore. Her main areas of practice are in corporate finance and M&A transactions throughout Asia. She has over 20 years’ experience in corporate and securities laws, advising on cross-border, transactions in addition to initial public offerings on the Singapore Stock Exchange.  Some of her complex deal structures have focused on various industries including healthcare and pharmaceuticals, fintech, natural resources, lifestyle and real estate and construction.   She also has extensive experience in investment funds, collective investment schemes and related regulatory and licensing requirements. Before joining the Firm, Claudia practiced with a local law firm and an international law firm in Singapore. Prior to that, she lived and worked abroad for 12 years in both London and Hong Kong, advising on initial public offerings and compliance issues on the Hong Kong Stock Exchange.

Claudia was recommended in the 2016 edition of The Legal 500 Asia-Pacific as well as in the 2014 edition of Asialaw Profiles and was described by Legal 500 Asia-Pacific as having  “flexible, walk-the-extra-mile approach” and “always goes the extra mile”.  One of her clients described her team as “very intelligent and incisive lawyers, absolutely focused on helping [us] achieve our objectives" in Asialaw Profiles 2016.  Her Practice Group has been awarded various accolades by leading legal publications. From 2017 to 2020, the team was ranked in the Asian Legal Business (ALB) M&A Guide. Her team was also recognized in both IFLR1000 and Asialaw Profiles from 2018 to 2021. The practice group has consistently been ranked by Legal 500 Asia-Pacific from 2018 to 2020 and most recently, her practice group is ranked in the 2021 edition of Chambers Asia-Pacific for Startups and Emerging Companies category. On her team’s strengths, clients commented "They really understand the products and how the business works without us having to explain. They are valuable partners to businesses and treasured legal advisers." One client remarks that the team is "on the ball, offering commercial feedback."

Claudia has been appointed as a director of Ren Ci Hospital & Medicare Centre, a Singapore charity healthcare institution, since 2018 and is also a member of the investment/governance & risk committee since 2013. She is also an independent director of iX Biopharma Ltd, an innovative late-stage specialty pharmaceutical company with expertise in drug delivery and formulation and The Hokkien Foundation, a charity providing financial support towards a wide range of social causes. Claudia was called to the Singapore Bar and is dually qualified as a barrister and a solicitor of England and Wales and is admitted to the Rolls of Solicitors of Hong Kong.

Recent Awards